M. Manzanares, F. Ramos-Martín, G. Casado-Fernández, M. Torres, E. Mateos, L. Vigón, . . . M. Coiras. (2022). OP 5.3 - 00082 1-year treatment with ponatinib provides protection of CD4+T cells against HIV that is maintained at least 1 year more after treatment interruption. Elsevier.
Chicago Style (17th ed.) CitationM. Manzanares, et al. OP 5.3 - 00082 1-year Treatment with Ponatinib Provides Protection of CD4+T Cells Against HIV That Is Maintained at Least 1 Year More After Treatment Interruption. Elsevier, 2022.
MLA (9th ed.) CitationM. Manzanares, et al. OP 5.3 - 00082 1-year Treatment with Ponatinib Provides Protection of CD4+T Cells Against HIV That Is Maintained at Least 1 Year More After Treatment Interruption. Elsevier, 2022.
Warning: These citations may not always be 100% accurate.